Biodyne

At a glance

Biodyne filed 25 disclosures in the last 12 months, including 5 insider and 5 5% holder. The most recent key filing was on Aug 14.

Revenue for 2025 was ₩7B, up 33.3% on 2024. Operating margin was 9.3% against -32.8% a year earlier. Debt was 2% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩1.5B and operating loss of ₩1.1B.

The 2025 annual report lists 23 employees with an average tenure of 3.5 years and average pay of ₩39.1M. Its 5 directors and auditors were paid ₩253.5M each on average. It paid no cash dividend for 2025. 임욱빈 and related parties held 41.85% at year end.

From the 2025 annual report

Staff: 23 (14 men, 9 women), of whom 3 on fixed-term contracts. Total pay for the year: ₩899.4M. Directors and auditors: 5, paid ₩1.3B in total.

No cash dividend was paid for 2025.

Largest shareholder

임욱빈 holds 40.39%; with 4 related parties the group holds 41.85% of common shares at year end (from 46.19% at the start of the year).

Individuals paid ₩500M or more

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary